Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023)
Journal of Analytical Toxicology · 2024
DOI: 10.1093/jat/bkae053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, 2024. Verfasst von Kevin G Shanks und 2 weiteren Autor:innen. Beteiligte Einrichtung: Axis Forensic Toxicology, 5780 W. 71st Street, Indianapolis, IN 46268, United States. Hauptthemen laut MEDLINE: Benzodiazepines, Forensic Toxicology, Substance Abuse Detection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
For the past 60 years, benzodiazepines such as chlordiazepoxide, diazepam, and alprazolam have been used as pharmaceutical medications for the treatment of myriad conditions including anxiety, seizures, and insomnia. In more recent years, novel benzodiazepine derivatives have emerged as illicit substances in powders and counterfeit tablets on the illicit drug market. In 2016, bromazolam, a brominated derivative of alprazolam, emerged on the illicit drug market in Europe, but the substance was not reported in the USA until 2019–2020. In this study, we report the emergence and subsequent prevalence of bromazolam in postmortem blood in the state of Indiana during 2023. Analysis was completed by a solvent protein precipitation extraction with acetonitrile and detection by liquid chromatography with quadrupole time of flight mass spectrometry. During 2023, bromazolam was detected in 94 cases across 25 counties in Indiana. It was never the sole substance detected and was commonly detected alongside fentanyl (83 cases), norfentanyl (77 cases), 4-anilino-N-phenethylpiperidine (76 cases), acetylfentanyl (49 cases), methamphetamine (32 cases), naloxone (25 cases), 11-nor-9-carboxy-tetrahydrocannabinol (24 cases), and benzoylecgonine (20 cases). After official query with the Indiana Department of Health, it was found that bromazolam was specifically included in the cause of death certification in 31 fatalities (32.9%). Due to the scarcity of information regarding this novel benzodiazepine derivative in postmortem toxicology and its involvement in fatalities, it is important that forensic toxicology laboratories consider adding bromazolam to their comprehensive scope of analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Axis Forensic Toxicology, 5780 W. 71st Street, Indianapolis, IN 46268, United States.
ORCID-Profile: Kevin G Shanks, George S Behonick
Zitieren
APA
Shanks, K. G., Kurtz, S. A. K., & Behonick, G. S. (2024). Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkae053
Vancouver
Shanks KG, Kurtz SAK, Behonick GS. Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023). Journal of Analytical Toxicology. 2024. doi:10.1093/jat/bkae053
BibTeX
@article{Shanks2024,
author = {Shanks, Kevin G and Kurtz, Stuart A K and Behonick, George S},
title = {Detection of the benzodiazepine bromazolam by liquid chromatography with quadrupole time of flight mass spectrometry in postmortem toxicology casework and prevalence in Indiana (2023)},
journal = {Journal of Analytical Toxicology},
year = {2024},
doi = {10.1093/jat/bkae053}
}
EUVIMED